UK govt to add Bharat Biotech's Covaxin to list of approved Covid vaccines from Nov 22

The UK government has said that India’s Covaxin will be added to its list of approved Covid-19 vaccines for international travellers from November 22, meaning that those inoculated with the Bharat Biotech-manufactured jab will not have to self-isolate after arrival in England.

The UK government has said that India’s Covaxin will be added to its list of approved Covid-19 vaccines for international travellers from November 22, meaning that those inoculated with the Bharat Biotech-manufactured jab will not have to self-isolate after arrival in England. The move follows the World Health Organisation’s (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India.

Covishield, the India-manufactured Oxford-AstraZeneca Covid-19 vaccine, was added to the UK’s approved list last month. “More good news for Indian travellers to the UK. From 22 November travellers fully vaccinated with a COVID19 vaccine recognised by WHO for Emergency Use Listing, including Covaxin, will not have to self-isolate; so joining those fully vaccinated with Covishield," Alex Ellis, British High Commissioner to India, said on Twitter on Monday.